Skip to main content

Certara, Inc.

corporate_fare Company Profile

Certara, Inc.

CERT·NASDAQ·Technology·CIK 0001827090

Our Company is a global leader in biosimulation science, technology, and consulting services, focusing on Model-Informed Drug Development ("MIDD") for the global biopharmaceutical and biotech industry. MIDD uses biological and statistical models from preclinical, clinical, and evidence data to guide decisions in drug research, development, and commercialization. Biosimulation, a key part of MIDD, employs computer-aided mathematical simulations of biological processes and systems to understand how a drug acts in humans or populations. This approach can increase the likelihood of a new drug reaching the market, speed up its development, and lower costs. Biosimulation supports drug development from discovery, preclinical stages, first-in-human dose predictions, clinical trial simulations, and protocol design, to drug interaction label claims. It also helps after approval with formulation or manufacturing changes and label extensions. MIDD strategies are increasingly used to predict commercial success. The pharmaceutical industry spends over $290 billion annually on research and development. Developing one new medicine typically takes 10-15 years and costs $6.2 billion, including the cost of failures.

Certara, Inc. (NASDAQ:CERT) is a publicly traded company in the Technology sector. Wiseek has independently scored 16 items for CERT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for CERT spans 8-K, 10-Q, DEF 14A, 10-K.

Recent high-impact activity:

  • Certara Q3 Revenue $94.9M, Software Up 11%; 2026 Growth Guidance Narrowed to 2-3%
  • Certara Narrows 2026 Revenue Outlook to 2-3% as Software Growth Hits 11%
  • Certara Posts Q2 Loss, Reaffirms Guidance, and Authorizes $50M Buyback
  • Certara's Q2 2026 Results: Wider Net Loss, Yet Guidance Reaffirmed and $50M Buyback Authorized
  • Certara Loses President and Chief Commercial Officer Leif Pedersen

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$418.84M
Net Income
-$1.59M
Diluted EPS
-$0.01
Op. Cash Flow
$96.33M
Free Cash Flow
$94.56M
Operating Income
$21.02M
Cash & Equivalents
$189.39M
Total Debt
$293.09M
Debt / Equity
0.28×
Net Margin
-0.4%
Shares Outstanding
159.14M sh
Source: 10-K · filed 2026-02-26 · accession 0001827090-26-000011

Short Interest & Short Volume

11.55 days to cover

FINRA reported short interest of 25,529,765 shares in CERT as of the October 30, 2026 settlement, a 0.6% decrease from the prior period — about 11.6 days to cover at its recent average daily volume. On November 20, 2026, 66.5% of CERT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)25,529,765 shares as of October 30, 2026
Change vs prior period▼ 0.6%
Days to cover11.55 at avg daily volume of 2,209,563
Daily short volume (FINRA facilities)66.5% of 492,948 shares on November 20, 2026
5-day average short volume64.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$10.55
52-week range · as of 2026-11-05 $4.45 – $11.88
Market cap
$1.61B
Volume
2.8M (1.1× avg)
3-mo avg 2.6M
Live data · 2026-11-22 05:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CERT - Latest Insights

CERT
Nov 05, 2026, 7:09 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.99
Real-time Price: $10.55 info
Change: -$0.440 (-4%) info
Market Cap: $1.609B info
CERT
Nov 05, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $10.55 info
Change: -$0.450 (-4%) info
Market Cap: $1.609B info
CERT
Aug 04, 2026, 7:19 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.55
Real-time Price: $10.55 info
Change: +$4.00 (+61%) info
Market Cap: $1.609B info
CERT
Aug 04, 2026, 7:09 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $10.55 info
Change: +$4.25 (+67%) info
Market Cap: $1.609B info
CERT
Aug 04, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.30
Real-time Price: $10.55 info
Change: +$4.25 (+67%) info
Market Cap: $1.609B info
CERT
Aug 04, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $10.55 info
Change: +$4.25 (+67%) info
Market Cap: $1.609B info
CERT
Jul 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $7.17
Real-time Price: $10.55 info
Change: +$3.39 (+47%) info
Market Cap: $1.609B info
CERT
Jun 17, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.04
Real-time Price: $10.55 info
Change: +$4.51 (+75%) info
Market Cap: $1.609B info
CERT
May 11, 2026, 6:33 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.37
Real-time Price: $10.55 info
Change: +$5.18 (+96%) info
Market Cap: $1.609B info
CERT
May 11, 2026, 6:28 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.75
Real-time Price: $10.55 info
Change: +$4.80 (+83%) info
Market Cap: $1.609B info
CERT
May 11, 2026, 6:25 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.22
Real-time Price: $10.55 info
Change: +$4.33 (+70%) info
Market Cap: $1.609B info
CERT
May 07, 2026, 8:02 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $6.35
Real-time Price: $10.55 info
Change: +$4.20 (+66%) info
Market Cap: $1.609B info
CERT
Apr 22, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $10.55 info
Change: +$4.25 (+67%) info
Market Cap: $1.609B info
CERT
Apr 03, 2026, 6:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $5.41
Real-time Price: $10.55 info
Change: +$5.14 (+95%) info
Market Cap: $1.609B info
CERT
Feb 26, 2026, 6:55 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $6.58
Real-time Price: $10.55 info
Change: +$3.97 (+60%) info
Market Cap: $1.609B info
CERT
Feb 26, 2026, 6:24 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.53
Real-time Price: $10.55 info
Change: +$4.02 (+62%) info
Market Cap: $1.609B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets